Neuren Pharmaceuticals Ltd

ASX:NEU (Australia)  
A$ 20.75 (+2.82%) Feb 23
47.59
P/B:
29.22
Market Cap:
A$ 2.69B ($ 1.76B)
Enterprise V:
A$ 2.61B ($ 1.71B)
Volume:
520.69K
Avg Vol (2M):
547.26K
Also Trade In:
Volume:
520.69K
Avg Vol (2M):
547.26K

Business Description

Description
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.94
Interest Coverage No Debt
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 915.32
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 51.8
3-Year Book Growth Rate 33.6
Name Current Vs Industry Vs History
5-Day RSI 42.98
9-Day RSI 39.21
14-Day RSI 40.98
6-1 Month Momentum % 87.86
12-1 Month Momentum % 223.28

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.04
Quick Ratio 16.04
Cash Ratio 14.26
Days Sales Outstanding 40.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.9
Shareholder Yield % -0.04

Financials

ASX:NEU's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Neuren Pharmaceuticals Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 62.926
EPS (TTM) (A$) 0.436
Beta 2.42
Volatility % 110.31
14-Day RSI 40.98
14-Day ATR (A$) 0.951032
20-Day SMA (A$) 22.1915
12-1 Month Momentum % 223.28
52-Week Range (A$) 7.01 - 25.95
Shares Outstanding (Mil) 129.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Neuren Pharmaceuticals Ltd Filings

Filing Date Document Date Form
No Filing Data

Neuren Pharmaceuticals Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Neuren Pharmaceuticals Ltd Frequently Asked Questions

What is Neuren Pharmaceuticals Ltd(ASX:NEU)'s stock price today?
The current price of ASX:NEU is A$20.75. The 52 week high of ASX:NEU is A$25.95 and 52 week low is A$7.01.
When is next earnings date of Neuren Pharmaceuticals Ltd(ASX:NEU)?
The next earnings date of Neuren Pharmaceuticals Ltd(ASX:NEU) is .
Does Neuren Pharmaceuticals Ltd(ASX:NEU) pay dividends? If so, how much?
Neuren Pharmaceuticals Ltd(ASX:NEU) does not pay dividend.

Press Release

Subject Date
No Press Release